Monday, January 25, 2021
Home Latest Pharma-News Zydus receives final approvals from the USFDA for Isosorbide Dinitrate Tablets for...

Zydus receives final approvals from the USFDA for Isosorbide Dinitrate Tablets for the treatment of Angina and Desonide Cream for skin diseases

Nov. 21, 2019: Zydus Cadila has received the final approval from the USFDA for marketing Isosorbide Dinitrate Tablets USP ( 5 mg, 10 mg, 20 mg, 30 mg and 40 mg)  to prevent attacks of Angina (chest pain).

These tablets dilate blood vessels, increases blood flow through to the heart. These will be manufactured at the group’s formulations manufacturing facility at Baddi. The group also received the final approval for Desonide Cream (US RLD – Desonide Cream), 0.05%.

- Advertisement -

The drug is a mild corticosteroid, used to treat a multiplicity of skin conditions (e.g., eczema, allergies, dermatitis, rash)in order to reduce swelling, itching and redness. It will be manufactured at the group’s Topical manufacturing facility at Ahmedabad. https://zyduscadila.com/public/pdf/pressrelease/Zydus_receives_final_approvals_from_the_USFDA_for_Isosorbide_Dinitrate_Tablets_and_Desonide_Cream.pdf

LEAVE A REPLY

Please enter your comment!
Please enter your name here

thirteen − ten =

Most Popular

What is the process for Submission of Synopsis?

1.1 a. "Prior to submission of a thesis synopsis, a comprehensive assessment of the research work should be carried out by a...

COVAX Announces new agreement, plans for first deliveries

January 22, 2021: COVAX, the global initiative to ensure rapid and equitable access to COVID-19 vaccines for all countries, regardless of income...

FDA Approves OPDIVO® with CABOMETYX® as First-line Treatment for advanced Renal Cell Carcinoma

22 Jan 2021:  Bristol Myers Squibb announced that OPDIVO®(nivolumab) 240 mg (injection for intravenous use) every two weeks or 480 mg every four weeks...

FDA granted approval of Cabenuva and Vocabria to ViiV Healthcare for HIV

January 21, 2021: "The U.S. FDA approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human...